Evidence map›Paper›PMID 40026680›Full record

ArticleArchives of physiotherapy

Scaling new heights: a pilot study of the impact of climbing on balance, agility, and dexterity in individuals with Parkinson's disease.

Julie D Ries, Molly Cupka, Andrew A Guccione

Abstract read
In one paragraph

Article in Archives of physiotherapy. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Julie D RiesCollege of Health and Education, School of Health Professions, Program in Physical Therapy, Marymount University, Arlington County, -Virginia - United States of America.ORCID https://orcid.org/0000-0001-8577-9479
Molly CupkaSportRock Climbing Centers, Alexandria, Virginia - United States of America.ORCID https://orcid.org/0009-0005-1747-5947
Andrew A GuccioneGeorge Mason University, Fairfax, Virginia - United States of America.ORCID https://orcid.org/0000-0002-1238-3585

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Exercise is known to be beneficial for individuals with Parkinson's disease (PD). Rock climbing contains exercise characteristics highlighted in published clinical guidelines for PD (e.g., aerobic, resistance, balance training, cued-movements, community-based) and also has unique somatosensory and visuospatial experiences that may facilitate motor learning. The purpose of this study was to investigate the effects of a climbing program on the physical function of individuals with PD. Methods: This quasi-experimental observational pilot study used pre-to-post-test comparisons to assess participants with mild to moderate PD (Hoehn and Yahr 1-3) who walked independently. The intervention was 12 weeks of community-based, twice weekly top-rope climbing sessions under one-on-one supervision and tailored to skill level. Wall angles, hand/foot holds, and routes varied from climb to climb and became progressively more difficult as skills increased. The primary outcome measure was the Community Balance & Mobility Scale (CBMS); secondary measures were the Agility T-Test (ATT), 9-Hole Peg Test (9HPT), upper extremity reaction time using BlazePods (UE-React), and grip strength (GS). Results: 28 participants completed the study: 8 women/20 men; mean age = 66.1 (sd = 7.4) years; average disease duration = 4.0 (sd = 3.6) years. Conclusions: Rock climbing demonstrated medium-size effects on mobility/balance and small-size effects on agility and dexterity that could impact functioning in everyday activities.

Indexed as

motor learningParkinson’s diseasephysical activityrehabilitation

Identifiers

PMID40026680
PMCPMC11868794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.